228 related articles for article (PubMed ID: 29523215)
1. Hydrogen sulfide promotes immunomodulation of gingiva-derived mesenchymal stem cells via the Fas/FasL coupling pathway.
Yang R; Yu T; Liu D; Shi S; Zhou Y
Stem Cell Res Ther; 2018 Mar; 9(1):62. PubMed ID: 29523215
[TBL] [Abstract][Full Text] [Related]
2. Acetylsalicylic acid rescues the immunomodulation of inflamed gingiva-derived mesenchymal stem cells via upregulating FasL in mice.
Yu T; Yan B; Li J; Zhang T; Yang R; Wang X; Liu Y; Liu D
Stem Cell Res Ther; 2019 Dec; 10(1):368. PubMed ID: 31796122
[TBL] [Abstract][Full Text] [Related]
3. [Acetylsalicylic acid treatment enhanced immunomodulatory function of mesenchymal stem cells derived from gingiva].
Yang RL; Yu TT; Zhou YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):872-877. PubMed ID: 29045972
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis.
Gu Y; Shi S
Arthritis Res Ther; 2016 Nov; 18(1):262. PubMed ID: 27836015
[TBL] [Abstract][Full Text] [Related]
5. Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells.
Xu X; Chen C; Akiyama K; Chai Y; Le AD; Wang Z; Shi S
J Dent Res; 2013 Sep; 92(9):825-32. PubMed ID: 23867762
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis.
Zhang Q; Shi S; Liu Y; Uyanne J; Shi Y; Shi S; Le AD
J Immunol; 2009 Dec; 183(12):7787-98. PubMed ID: 19923445
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis.
Akiyama K; Chen C; Wang D; Xu X; Qu C; Yamaza T; Cai T; Chen W; Sun L; Shi S
Cell Stem Cell; 2012 May; 10(5):544-55. PubMed ID: 22542159
[TBL] [Abstract][Full Text] [Related]
8. Osthole enhances the immunosuppressive effects of bone marrow-derived mesenchymal stem cells by promoting the Fas/FasL system.
Yu Y; Chen M; Yang S; Shao B; Chen L; Dou L; Gao J; Yang D
J Cell Mol Med; 2021 May; 25(10):4835-4845. PubMed ID: 33749126
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide promotes lipopolysaccharide-induced apoptosis of osteoblasts by inhibiting the AKT/NF-κB signaling pathway.
Wang H; Li X; Zhu Z; Wang H; Wei B; Bai X
Biochem Biophys Res Commun; 2020 Apr; 524(4):832-838. PubMed ID: 32037087
[TBL] [Abstract][Full Text] [Related]
10. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A
J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E2-EP3 signaling.
Li P; Zhao Y; Ge L
Stem Cell Res Ther; 2016 Aug; 7(1):103. PubMed ID: 27484807
[TBL] [Abstract][Full Text] [Related]
12. Redundant let-7a suppresses the immunomodulatory properties of BMSCs by inhibiting the Fas/FasL system in osteoporosis.
Liao L; Yu Y; Shao B; Su X; Wang H; Kuang H; Jing H; Shuai Y; Yang D; Jin Y
FASEB J; 2018 Apr; 32(4):1982-1992. PubMed ID: 29203591
[TBL] [Abstract][Full Text] [Related]
13. Updates on GMSCs Treatment for Autoimmune Diseases.
Huang F; Liu ZM; Zheng SG
Curr Stem Cell Res Ther; 2018; 13(5):345-349. PubMed ID: 29468980
[TBL] [Abstract][Full Text] [Related]
14. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
15. Human gingiva-derived mesenchymal stem cells alleviate inflammatory bowel disease via IL-10 signalling-dependent modulation of immune cells.
Lu Y; Xu Y; Zhang S; Gao J; Gan X; Zheng J; Lu L; Zeng W; Gu J
Scand J Immunol; 2019 Sep; 90(3):e12751. PubMed ID: 30664802
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Suppression of Immune Cells In Vitro by MSC Overexpressing FasL.
Vacaru AM; Dumitrescu M; Vacaru AM; Fenyo IM; Ionita R; Gafencu AV; Simionescu M
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396269
[TBL] [Abstract][Full Text] [Related]
17. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
19. Gingiva-derived Mesenchymal Stem Cells and Their Potential Applications in Oral and Maxillofacial Diseases.
Gao X; Cao Z
Curr Stem Cell Res Ther; 2020; 15(1):43-53. PubMed ID: 31702517
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypoxia on the immunomodulatory properties of human gingiva-derived mesenchymal stem cells.
Jiang CM; Liu J; Zhao JY; Xiao L; An S; Gou YC; Quan HX; Cheng Q; Zhang YL; He W; Wang YT; Yu WJ; Huang YF; Yi YT; Chen Y; Wang J
J Dent Res; 2015 Jan; 94(1):69-77. PubMed ID: 25403565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
